TAMMY TAYLOR: Open Payments
NPI 1346317583 · CHESTERFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$704 in 39 payments from 12 companies in 2025. Trend: 2023 $234 · 2024 $412 · 2025 $704
Food & beverage: $704
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $235 |
| PFIZER INC. | 10 | $137 |
| Lilly USA, LLC | 4 | $81 |
| Exact Sciences Corporation | 2 | $48 |
| Janssen Biotech, Inc. | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Globus Medical, Inc. | 1 | $29 |
| Grifols USA, LLC | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| TMS NeuroHealth Centers Inc. | 1 | $19 |
Products named: UBRELVY, MOUNJARO, NURTEC ODT, QULIPTA, Cologuard Collection Kit, VRAYLAR, VENCLEXTA, SHINGRIX.
Industry payments across MO — which companies pay providers there.
